Analyst Ratings For NASDAQ:CELG – Celgene (NASDAQ:CELG)
Today, NASDAQ:CELG – Celgene (NASDAQ:CELG) stock was downgraded by Argus from Buy ➝ Hold to .
Some recent analyst ratings include
- 5/23/2018-Argus was Downgraded by analysts at Argus from a “Buy ➝ Hold” rating to a “” rating.
- 5/23/2018-Sanford C. Bernstein Upgrade from a “Market Perform ➝ Outperform” rating to a “” rating.
- 5/7/2018-Leerink Swann Reiterated Rating of Buy.
- 5/7/2018-Royal Bank of Canada was Downgraded by analysts at Royal Bank of Canada from a “Top Pick ➝ Outperform” rating to a “” rating. They now have a $120.00 price target on the stock.
Recent Insider Trading Activity For NASDAQ:CELG – Celgene (NASDAQ:CELG)
NASDAQ:CELG – Celgene (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 75.69%.
- On 5/18/2018 Gilla Kaplan, Director, sold 27,750 with an average share price of $78.66 per share and the total transaction amounting to $2,182,815.00.
- On 5/9/2018 Mark J Alles, CEO, bought 1,208 with an average share price of $82.60 per share and the total transaction amounting to $99,780.80.
- On 3/12/2018 James J Loughlin, Director, sold 9,250 with an average share price of $92.01 per share and the total transaction amounting to $851,092.50.
- On 2/23/2018 Ernest Mario, Director, sold 13,370 with an average share price of $94.49 per share and the total transaction amounting to $1,263,331.30.
- On 2/20/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $94.83 per share and the total transaction amounting to $877,177.50.
- On 2/15/2018 Gilla Kaplan, Director, sold 9,250 with an average share price of $95.99 per share and the total transaction amounting to $887,907.50.
- On 2/8/2018 Mark J Alles, Insider, bought 3,260 with an average share price of $91.90 per share and the total transaction amounting to $299,594.00.
Recent Trading Activity for NASDAQ:CELG – Celgene (NASDAQ:CELG)
Shares of NASDAQ:CELG – Celgene closed the previous trading session at 77.52 up +0.91 1.19% with 3477713 shares trading hands.